{"id":"https://openalex.org/W2016474992","doi":"https://doi.org/10.1016/s0009-9236(98)90072-8","title":"Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*","display_name":"Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*","publication_year":1998,"publication_date":"1998-10-01","ids":{"openalex":"https://openalex.org/W2016474992","doi":"https://doi.org/10.1016/s0009-9236(98)90072-8","mag":"2016474992","pmid":"https://pubmed.ncbi.nlm.nih.gov/9797798"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(98)90072-8","doi":"https://doi.org/10.1016/s0009-9236(98)90072-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90072-8","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109119401","display_name":"Wing K. Cheung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Wing K. Cheung","raw_affiliation_strings":["Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019613309","display_name":"Betty L. Goon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty L. Goon","raw_affiliation_strings":["Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091691946","display_name":"Mary Guilfoyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary C. Guilfoyle","raw_affiliation_strings":["Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069977506","display_name":"Mary C. Wacholtz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary C. Wacholtz","raw_affiliation_strings":["Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Drug Metabolism and Global Clinical Research and Development, R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109119401"],"corresponding_institution_ids":["https://openalex.org/I4405282460"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.7628,"has_fulltext":false,"cited_by_count":111,"citation_normalized_percentile":{"value":0.89678915,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"64","issue":"4","first_page":"412","last_page":"423"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.9309999942779541},{"id":"https://openalex.org/keywords/recombinant-human-erythropoietin","display_name":"recombinant human erythropoietin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8550000190734863},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.7540000081062317},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.8270000219345093},{"id":"https://openalex.org/keywords/reticulocytes","display_name":"reticulocytes","score":0.7710000276565552},{"id":"https://openalex.org/keywords/dose-dependent-clearance","display_name":"dose-dependent clearance","score":0.7419999837875366},{"id":"https://openalex.org/keywords/dose-saturation","display_name":"dose saturation","score":0.5550000071525574},{"id":"https://openalex.org/keywords/serum-ferritin","display_name":"serum ferritin","score":0.8939999938011169},{"id":"https://openalex.org/keywords/iron-supplementation","display_name":"iron supplementation","score":0.8349999785423279},{"id":"https://openalex.org/keywords/anemia-treatment","display_name":"anemia treatment","score":0.75},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.8780943155288696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8321841955184937},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.8309313058853149},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8221718072891235},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7085320949554443},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6506468057632446},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4886987507343292},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4551219940185547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.347251296043396},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005293","descriptor_name":"Ferritins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006400","descriptor_name":"Hematocrit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007501","descriptor_name":"Iron","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007501","descriptor_name":"Iron","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017701","descriptor_name":"Reticulocyte Count","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(98)90072-8","doi":"https://doi.org/10.1016/s0009-9236(98)90072-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90072-8","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:9797798","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9797798","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W645138306","https://openalex.org/W1528664908","https://openalex.org/W1534550394","https://openalex.org/W1966621021","https://openalex.org/W1983385242","https://openalex.org/W2019289959","https://openalex.org/W2038179113","https://openalex.org/W2043332082","https://openalex.org/W2043588000","https://openalex.org/W2076374657","https://openalex.org/W2077030445","https://openalex.org/W2078455749","https://openalex.org/W2079059080","https://openalex.org/W2126667419","https://openalex.org/W2137333423","https://openalex.org/W2157534399","https://openalex.org/W2288936396","https://openalex.org/W2336116827","https://openalex.org/W2411064379","https://openalex.org/W2413526911"],"related_works":["https://openalex.org/W1970838504","https://openalex.org/W1971734795","https://openalex.org/W2043588000","https://openalex.org/W1983849763","https://openalex.org/W2082490162","https://openalex.org/W2085423203","https://openalex.org/W2172143060","https://openalex.org/W2005309438","https://openalex.org/W4298465553","https://openalex.org/W2097511323"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"understand":[2],"the":[3,130,144,188,242,290,321],"pharmacokinetic":[4],"and":[5,14,55,58,73,133,178,301],"pharmacodynamic":[6],"properties":[7],"of":[8,25,29,47,95,103,126,152,157,191,215,223,245,282,299,306,320,325],"recombinant":[9],"human":[10],"erythropoietin":[11,134],"(epoetin":[12],"alfa)":[13],"to":[15,17,140,163,168,176,180,218,293],"continue":[16],"optimize":[18],"dosing":[19,302],"regimens":[20,161,196,207],"by":[21,165,183,270],"determining":[22],"whether":[23],"administration":[24,100,305,319],"single":[26,44,137],"high":[27],"doses":[28,46,138,281],"epoetin":[30,96,229,283,294,307,326],"alfa":[31,40,97,230,295,308],"is":[32,296],"as":[33,35,43,124,205],"effective":[34,311],"repeated":[36],"administration.":[37],"METHODS:":[38],"Epoetin":[39],"was":[41,101,107,117,149,238,263,309],"administered":[42],"subcutaneous":[45,61,99],"300,":[48],"450,":[49],"600,":[50],"900,":[51],"1200,":[52],"1350,":[53],"1800,":[54],"2400":[56],"IU/kg":[57,65,75,146,228,250],"in":[59,82,88,109,213,276,312],"multiple":[60,280],"dose":[62,300],"regimens:":[63],"150":[64,249],"3":[66,167,251],"times":[67,252],"a":[68,118,150,233,253,297,314],"week":[69,78,234,254],"for":[70,79,136,226,235,248,255],"4":[71,80,236,256],"weeks":[72,81,237],"600":[74,227],"once":[76,232],"per":[77],"2":[83],"open-label,":[84],"randomized":[85],"placebo-controlled":[86],"studies":[87],"healthy":[89],"volunteers.":[90],"RESULTS:":[91],"The":[92,154,220],"absorption":[93],"rate":[94],"after":[98,159,193],"independent":[102],"dose,":[104,147],"whereas":[105],"clearance":[106],"dose-dependent":[108],"that":[110,289],"it":[111],"decreased":[112],"with":[113,279],"increasing":[114],"dose.":[115],"There":[116],"linear":[119],"relationship":[120],"between":[121],"response":[122,292,316],"measured":[123],"percentage":[125,156,190,214,222,244],"reticulocytes":[127,158,192,216,224,246],"area":[128],"under":[129],"curve":[131],"(AUC)":[132],"AUC":[135,225,247],"up":[139],"1800":[141,145],"IU/kg.":[142],"Beyond":[143],"there":[148],"saturation":[151],"response.":[153],"mean":[155,189,221,243,265],"single-dose":[160,318],"began":[162],"increase":[164],"days":[166,174],"4,":[169],"reached":[170],"their":[171],"maximum":[172],"at":[173],"8":[175],"11,":[177],"returned":[179],"baseline":[181,200],"values":[182,201],"day":[184,203,274],"22.":[185],"In":[186],"contrast,":[187],"both":[194,206],"multiple-dose":[195],"were":[197],"maintained":[198],"above":[199],"through":[202,273],"22":[204,275],"stimulated":[208],"modest":[209],"but":[210],"sustained":[211],"increases":[212],"(1%":[217],"2%).":[219],"given":[231],"apparently":[239],"greater":[240],"than":[241,317],"weeks.":[257],"Although":[258],"daily":[259],"oral":[260],"iron":[261],"supplementation":[262],"given,":[264],"serum":[266],"ferritin":[267],"levels":[268],"declined":[269],"approximately":[271],"75%":[272],"subjects":[277],"treated":[278],"alfa.":[284,327],"CONCLUSIONS:":[285],"These":[286],"findings":[287],"show":[288],"pharmacologic":[291],"function":[298],"regimen.":[303],"Repeated":[304],"more":[310],"stimulating":[313],"reticulocyte":[315],"same":[322],"total":[323],"amount":[324]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}